TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
+9.19%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$1.2B
AUM Growth
-$255M
(-17%)
Cap. Flow
-$347M
Cap. Flow
% of AUM
-28.78%
Top 10 Holdings %
Top 10 Hldgs %
51.29%
Holding
4,943
New
707
Increased
1,155
Reduced
1,650
Closed
1,315
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$176M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$164M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$24.4M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$19.8M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$15.7M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$53.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$24.1M |
| 3 |
Apple
AAPL
|
+$23.1M |
| 4 |
Visa
V
|
+$22M |
| 5 |
Microsoft
MSFT
|
+$20.1M |
Sector Composition
| 1 | Technology | 2.74% |
| 2 | Financials | 2.53% |
| 3 | Healthcare | 2.3% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Industrials | 1.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Welltower
WELL
$112B
| $173K | 0.01% |
2,114
-5,608
| -73% | -$459K |
|
652
Teva Pharmaceuticals
TEVA
$22.4B
| $172K | 0.01% |
17,582
+17,229
| +4,881% | +$169K |
|
653
Crown Holdings
CCK
$11B
| $170K | 0.01% |
2,335
+2,233
| +2,189% | +$163K |
|
|
HUYA
654
Huya Inc
HUYA
$740M
| $170K | 0.01% |
9,465
+7,840
| +482% | +$141K |
|
655
Stifel
SF
$11.6B
| $170K | 0.01% |
4,194
+2,797
| +200% | +$113K |
|
|
ISBC
656
DELISTED
Investors Bancorp, Inc.
ISBC
| $170K | 0.01% |
14,292
+6,993
| +96% | +$83.2K |
|
657
Philip Morris
PM
$257B
| $169K | 0.01% |
1,992
-19,421
| -91% | -$1.65M |
|
658
KraneShares CSI China Internet ETF
KWEB
$8.87B
| $168K | 0.01% |
+3,457
| New | +$168K |
|
659
Vanguard Mega Cap Value ETF
MGV
$9.91B
| $168K | 0.01% |
1,922
-6,972
| -78% | -$609K |
|
660
OneMain Financial
OMF
$7.22B
| $168K | 0.01% |
3,975
+3,486
| +713% | +$147K |
|
661
Ziff Davis
ZD
$1.5B
| $168K | 0.01% |
2,056
+1,020
| +98% | +$83.3K |
|
662
AstraZeneca
AZN
$251B
| $167K | 0.01% |
3,357
-8,035
| -71% | -$400K |
|
663
Nasdaq
NDAQ
$54.3B
| $167K | 0.01% |
4,689
-7,266
| -61% | -$259K |
|
664
SAP
SAP
$303B
| $167K | 0.01% |
1,244
+282
| +29% | +$37.9K |
|
665
Werner Enterprises
WERN
$1.66B
| $167K | 0.01% |
4,594
+4,247
| +1,224% | +$154K |
|
666
Kura Oncology
KURA
$709M
| $166K | 0.01% |
12,035
+9,066
| +305% | +$125K |
|
|
SA
667
Seabridge Gold
SA
$1.8B
| $166K | 0.01% |
12,053
+3,569
| +42% | +$49.2K |
|
|
SVC
668
Service Properties Trust
SVC
$469M
| $166K | 0.01% |
6,818
+5,238
| +332% | +$128K |
|
|
UBIO
669
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
| $166K | 0.01% |
5,075
-8,839
| -64% | -$289K |
|
|
CGC
670
Canopy Growth
CGC
$434M
| $165K | 0.01% |
783
+251
| +47% | +$52.9K |
|
671
Rockwell Automation
ROK
$38.2B
| $165K | 0.01% |
813
-3,098
| -79% | -$629K |
|
|
MAXR
672
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $165K | 0.01% |
10,596
-4,595
| -30% | -$71.6K |
|
673
H&R Block
HRB
$6.73B
| $164K | 0.01% |
6,994
-172
| -2% | -$4.03K |
|
674
Myriad Genetics
MYGN
$642M
| $164K | 0.01% |
+6,039
| New | +$164K |
|
|
AKCA
675
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $164K | 0.01% |
+9,672
| New | +$164K |
|